38.93 0.00 (0.00%)
After hours: 4:58PM EDT
|Bid||35.10 x 1100|
|Ask||40.79 x 900|
|Day's Range||37.55 - 39.69|
|52 Week Range||24.84 - 42.64|
|Beta (3Y Monthly)||1.65|
|PE Ratio (TTM)||659.83|
|Earnings Date||Jul 29, 2019 - Aug 2, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||44.50|
Masimo (MASI) receives FDA 510 (k) clearance for Radius PPG, which is set to become an important breakthrough in patient monitoring.
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex volatility remains a concern.
DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, divestment of DMG segment might lower cash flows.
PerkinElmer (PKI) is gaining steadily from its core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of 150.00% and 0.82%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
The St. Paul, Minnesota-based company said it had net income of 2 cents per share. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ...
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). By way of learning-by-doing, we'll look at ROE...
Cardiovascular Systems (CSII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cardiovascular Systems (CSII) hopes that new product menu will deliver minimum 10% growth in its core business during the second half of fiscal 2019.
Scott Ward became the CEO of Cardiovascular Systems, Inc. (NASDAQ:CSII) in 2016. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider growth thatRead More...
Cardiovascular Systems, Inc. , a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral
NEW YORK , March 1, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: Washington Real Estate Investment Trust (NYSE: WRE) will replace Investment Technology ...
Wright Medical's (WMGI) top-line growth in fourth-quarter 2018 can be attributed to solid performance by the Upper and the Lower Extremities segments.
With regard to its 2019 PBM selling season, CVS Health (CVS) notes that the net benefits from this selling season are expected to be modest on Anthem-related headwinds.
DaVita (DVA) steadily expands in international markets. Moreover, the company has witnessed Dialysis services in the United States lately.